top of page
MICA Biosystems uses cutting-edge, first-in-class nanobiotechnology to enable researchers to propel this frontier of science and medicine, truly unlocking the potential of controlling cells remotely.
MICA - Magnetic Ion Channel Activation
We have developed a pioneering biomagnetic technology designed to remotely deliver directed mechanical stimuli to individual cells within culture or within the body.
Recently MICA Biosystems was recognised in the Global Health & Pharma Biotechnology Awards 2022 & 2023 for its groundbreaking work and bestowed with the title of the UK’s Stem Cell Therapy Innovators of the Year for two consecutive years.
What We Do
MICA Biosystems holds a diverse product/therapy portfolio, reflecting an extensive R&D effort since its inception and founded by world-class researchers in biotechnology, cell engineering, regenerative medicine, and bioengineering.
What We Do
MICA Cell Therapy
Revolutionising Regenerative Medicine
We use nanoparticles and an induced magnetic field to actively and accurately control the differentiation of stem cells in vivo in a highly location-specific, minimally-invasive procedure. Currently, MICA is pursuing clinical trials in Spinal Repair after successful preclinical trials in mammals, using this technology to aid in-spinal fusion.
Patented Drug Screening Platform
Our patented drug screening platform provides mechanical stimulation to cells in an assay as a bolt-on addition to existing instrumentation and methodologies. This low-cost, low-impact solution applies to a range of assays and is not cell-line specific with incredible peer-reviewed data to prove its efficacy.
MICA Magnetic Bioreactor
Our bioreactor enables new approaches to tissue engineering, regenerative medicine, drug discovery, and therapy via novel magnetic ion channel activation. Using our patented instrumentation, nanotechnology, and magnetic forces provide mechanical stimulation to cell cultures and facilitate 3D structure and organoid cell cultures.
bottom of page